OR WAIT null SECS
May 02, 2018
Public health authorities and the biomedical research community are seeking new strategies to address global health threats.
March 29, 2018
Congress passed a $1.3-trillion omnibus budget bill March 22, 2018 that increases federal support for biomedical research and health programs for fiscal year 2018.
March 08, 2018
The FDA commissioner outlined the agency's initiatives to reward innovation and biosimilars development.
February 14, 2018
The Trump budget boosts funding for FDA but squeezes resources for NIH and healthcare.
February 08, 2018
Gottlieb promoted the development of biosimilars and safer opioid packaging at a briefing sponsored by Alliance for a Stronger FDA and the Pew Charitable Trusts.
February 05, 2018
New programs and initiatives by industry examine rising healthcare costs.
February 01, 2018
The President described US drug costs as unfair and stated that prices will come down.
January 31, 2018
FDA and industry weigh broader use of prior knowledge in biotechnology testing and production.
January 10, 2018
Will Alex Azar’s experience in the pharmaceutical industry help or hurt the initiative to keep medications affordable?
December 20, 2017
New tax legislation may result in savings for biopharma companies.